NCT02089113View on ClinicalTrials.gov

OTX-14-003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

March 31, 2015

Conditions
Post-Surgical Ocular PainPost-Surgical Ocular Inflammation
Interventions
DRUG

Dexamethasone

PROCEDURE

Placebo Vehicle

Sponsors
All Listed Sponsors
lead

Ocular Therapeutix, Inc.

INDUSTRY